Freenome, Inc. - Common stock (FRNM)

10.91
+0.00 (0.00%)
NASDAQ· Last Trade: Aug 5th, 8:43 AM EDT
QuoteNewsPress ReleasesChartHistoricalFAQAboutCompetitors

Detailed Quote

Previous Close10.91
Open-
Bid10.76
Ask11.17
Day's RangeN/A - N/A
52 Week Range9.970 - 14.26
Volume1,320
Market Cap-
PE Ratio (TTM)-
EPS (TTM)-
Dividend & YieldN/A (N/A)
1 Month Average Volume784,383

Chart

News & Press Releases

FDA Approves Freenome’s SimpleScreen™ CRC Blood-Based Screening Test; Abbott to Commercialize in the U.S.
– Approval expands colorectal cancer screening options for the up to 60 million Americans who are overdue for screening –
By Freenome, Inc. · Via GlobeNewswire · July 27, 2026